Product
2HPZM
1 clinical trial
1 indication
Indication
HIV-associated TuberculosisClinical trial
Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated TuberculosisStatus: Recruiting, Estimated PCD: 2025-02-28